Your browser doesn't support javascript.
loading
Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.
Kordes, M; Röring, M; Heining, C; Braun, S; Hutter, B; Richter, D; Geörg, C; Scholl, C; Gröschel, S; Roth, W; Rosenwald, A; Geissinger, E; von Kalle, C; Jäger, D; Brors, B; Weichert, W; Grüllich, C; Glimm, H; Brummer, T; Fröhling, S.
Afiliación
  • Kordes M; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Röring M; Department of Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany.
  • Heining C; Institute of Molecular Medicine and Cell Research, Faculty of Medicine, BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
  • Braun S; German Cancer Consortium (DKTK), Freiburg, Germany.
  • Hutter B; Department of Translational Oncology, NCT Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Richter D; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Geörg C; DKTK, Heidelberg, Germany.
  • Scholl C; Institute of Molecular Medicine and Cell Research, Faculty of Medicine, BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
  • Gröschel S; German Cancer Consortium (DKTK), Freiburg, Germany.
  • Roth W; DKTK, Heidelberg, Germany.
  • Rosenwald A; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, Heidelberg, Germany.
  • Geissinger E; Department of Translational Oncology, NCT Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • von Kalle C; DKTK, Heidelberg, Germany.
  • Jäger D; Department of Translational Oncology, NCT Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brors B; DKTK, Heidelberg, Germany.
  • Weichert W; DKFZ-Heidelberg Center for Personalized Oncology (HIPO), Heidelberg, Germany.
  • Grüllich C; Department of Translational Oncology, NCT Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Glimm H; DKTK, Heidelberg, Germany.
  • Brummer T; Department of Translational Oncology, NCT Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fröhling S; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Leukemia ; 30(4): 937-46, 2016 Apr.
Article en En | MEDLINE | ID: mdl-26582644
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Proteínas Proto-Oncogénicas p21(ras) / Proteínas Proto-Oncogénicas B-raf / Sarcoma Histiocítico / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Humans / Male Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Proteínas Proto-Oncogénicas p21(ras) / Proteínas Proto-Oncogénicas B-raf / Sarcoma Histiocítico / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Humans / Male Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido